Development and characterization of an antibody that recognizes influenza virus N1 neuraminidases

• Nan Chen,

  Roles Data curation, Formal analysis, Validation, Writing – original draft

  Affiliation State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing, China

  https://orcid.org/0009-0007-6538-7487

  ⨯
• Renxi Wang,

  Roles Writing – review & editing

  Affiliation Laboratory of Brain Disorders, Collaborative Innovation Center for Brain Disorders, Beijing Institute of Brain Disorders, Capital Medical University, Ministry of Science and Technology, Beijing, China

  ⨯
• Wanlu Zhu,

  Roles Validation

  Affiliations State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing, China, Joint National Laboratory for Antibody Drug Engineering, The First Affiliated Hospital, School of Medicine, Henan University, Kaifeng, China

  ⨯
• Xiangjun Hao,

  Roles Validation

  Affiliations State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing, China, Joint National Laboratory for Antibody Drug Engineering, The First Affiliated Hospital, School of Medicine, Henan University, Kaifeng, China

  ⨯
• Jing Wang,

  Roles Supervision

  Affiliation State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing, China

  ⨯
• Guojiang Chen,

  Roles Methodology

  Affiliation State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing, China

  ⨯
• ChunXia Qiao,

  Roles Writing – review & editing

  Affiliation State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing, China

  ⨯
• Xinying Li,

  Roles Writing – review & editing

  Affiliation State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing, China

  ⨯
• Chenghua Liu,

  Roles Methodology

  Affiliation State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing, China

  ⨯
• Beifen Shen,

  Roles Project administration

  Affiliation State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing, China

  ⨯
• Jiannan Feng,

  Roles Project administration

  Affiliation State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing, China

  ⨯
• Lihui Chai ,

  Roles Supervision, Writing – review & editing

  * E-mail: xiaoheysy@163.com (HX); yuzy79@163.com (ZY); clh0301@henu.edu.cn (LC)

  Affiliation Joint National Laboratory for Antibody Drug Engineering, The First Affiliated Hospital, School of Medicine, Henan University, Kaifeng, China

  ⨯
• Zuyin Yu ,

  Roles Supervision, Writing – review & editing

  * E-mail: xiaoheysy@163.com (HX); yuzy79@163.com (ZY); clh0301@henu.edu.cn (LC)

  Affiliation Department of Experimental Hematology and Biochemistry, Beijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, Beijing, China

  https://orcid.org/0000-0001-7037-4479

  ⨯
• He Xiao

  Roles Formal analysis, Methodology, Supervision, Validation, Writing – review & editing

  * E-mail: xiaoheysy@163.com (HX); yuzy79@163.com (ZY); clh0301@henu.edu.cn (LC)

  Affiliation State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing, China

  https://orcid.org/0009-0005-3482-8353

  ⨯